Shanghai Haoyuan Chemexpress Co., Ltd. (SHA:688131)

SHA:688131 Revenue

Shanghai Haoyuan Chemexpress had revenue of 919.32M CNY in the quarter ending June 30, 2026, with 30.43% growth. This brings the company's total for the last twelve months to 3.21B, up 27.26% year-over-year. In the year 2025, Shanghai Haoyuan Chemexpress had annual revenue of 2.88B with 26.73% growth. That makes Shanghai Haoyuan Chemexpress the 11,456th largest company in the world by revenue and 1,927th in China.

• Revenue (ttm): 3.21B
• Revenue Growth: +27.26%
• P/S Ratio: 5.53
• Revenue / Employee: 707.91K
• Employees: 4,540
• Market Cap: 17.78B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Molecular Building Blocks, Tool Compounds and Biochemical Reagents 1.99B 69.5%
• Active Pharmaceutical Ingredient, Intermediate and Preparations 872.24M 30.5%

By Geography

Chart

• China 1.71B 59.6%
• Overseas 1.16B 40.4%

Fiscal year ended Dec 31, 2025 See the full SHA:688131 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.88B	606.72M	26.73%
Dec 31, 2024	2.27B	390.13M	20.75%
Dec 31, 2023	1.88B	521.99M	38.44%
Dec 31, 2022	1.36B	388.83M	40.12%
Dec 31, 2021	969.23M	334.12M	52.61%

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error